{"id":"W3006147702","doi":"10.1158/1538-7445.sabcs19-p1-19-10","title":"Abstract P1-19-10: Safety and efficacy of abemaciclib plus endocrine therapy (ET) in elderly patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+, HER2-) advanced breast cancer: An age-specific subgroup analysis of MONARCH 2 and 3 trials","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Internal medicine; Fulvestrant; Breast cancer; Letrozole; Anastrozole; Oncology; Metastatic breast cancer; Placebo; Tolerability; Adverse effect; Cancer; Tamoxifen; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002681826,0.0006901362,0.001872722,0.0004868189,0.0002243032,0.0009830071,0.0004233808,0.000513075,0.002916856],"category_scores_gemma":[0.001883532,0.000200948,0.004631782,0.0005556303,0.0003001636,0.0005130087,0.0004483034,0.001103668,0.0003183991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005181577,"about_ca_system_score_gemma":0.0007922254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005504752,"about_ca_topic_score_gemma":0.002931414,"domain_scores_codex":[0.9990469,0.00044478,0.0001561919,0.0001416964,0.0001091918,0.0001013163],"domain_scores_gemma":[0.9991809,0.0002573955,0.000282787,0.00008488641,0.00007794892,0.0001161933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7649438,0.001539864,0.03675113,0.008007953,0.06581283,0.0003104191,0.0001668774,0.001693332,0.01203896,0.0003859303,0.005027941,0.1033209],"study_design_scores_gemma":[0.4258766,0.1158029,0.276029,0.001557947,0.1380606,0.001363868,0.0004191758,0.003995886,0.008129242,0.002691978,0.02586766,0.0002051269],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9460038,0.04094826,0.0009387442,0.0006193264,0.0001861099,0.001875248,0.005630033,0.00007049518,0.003728039],"genre_scores_gemma":[0.9891561,0.00429215,0.0006474901,0.0005644486,0.0001416071,0.0008915972,0.002966489,0.00001601695,0.001323916],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002916856,"threshold_uncertainty_score":0.01418298,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07795745802238126,"score_gpt":0.3975921194769834,"score_spread":0.3196346614546021,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}